Oxaliplatin

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
05011
Time finding study of chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as first or second chemotherapy line against metastatic colorectal cancer.
40004
CLOCC trial (Chemotherapy + Local ablation versus Chemotherapy). Randomized phase II study investigating the role of local treatment of liver metastases by radiofrequency combined with chemotherapy and of chemotherapy alone in patients with unresectable colorectal liver metastases.
40054
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaplatin vs.capecitabine alone in locally advanced rectal cancer (PETACC-6).
40051
Randomized phase II trial evaluating the feasibility and tolerance of the combination of FOLFOX with cetuximab and the combination of FOLFOX with cetuximab and bevacizumab as perioperative treatment in patients with resectable liver metastases from colorectal cancer (BOS).
16029
Phase I study of PS-341 (VELCADE)in combination with 5FU/LV plus oxaliplatin in patients with advanced colorectal cancer
16033
A phase I study of OSI-7904L in combination with oxaliplatin in patients with advanced colo-rectal cancer

Back to Protocol section